| ¿µ¹® | five-year survival rate | ÇÑ±Û | ¿À³â»ýÁ¸À² |
|---|---|---|---|
| ¼³¸í | 1. µ¿ÀÏ Áúº´ÀÇ Áø´Ü ȤÀº Ä¡·á ÈÄ, 5³âÀÌ °æ°ú µÈ µÚÀÇ »ýÁ¸ÀÚ¼öÀÇ Ç¥Çö. 2. ¾ÏÀÇ Áø´Ü ¶Ç´Â Ä¡·á µÚ¿¡ °Ë»ç¸¦ ¹Ýº¹ÇÏ¿© 5³â µ¿¾È »ì¾Æ ÀÖ´Â »ç¶÷ÀÇ ¹éºÐÀ². Ä¡·á ÈÄ 5³â µ¿¾È »ýÁ¸Çϸé ÀÏ´Ü Ä¡À¯µÈ °ÍÀ¸·Î °£ÁÖÇÑ´Ù. |
||
| ¿µ¹® | liver function tests | ÇÑ±Û | °£±â´É°Ë»ç |
|---|---|---|---|
| ¼³¸í | Ç÷¾×°Ë»çÁß °¡Àå ¸¹ÀÌ ¾²ÀÌ´Â °Ë»ç¹ýÀ¸·Î ´ÙÀ½ 7°¡Áö¸¦ °Ë»çÇÏ°Ô µÈ´Ù. Ç÷ûÄÝ·¹½ºÅ×·Ñ, ÃѴܹéÁú, ¾ËºÎ¹Î, ºô¸®·çºó, GOT/GPT È¿¼Ò, ¾ËÄ®¸®ÀλêºÐÇØÈ¿¼Ò(alkaline phophatase) µîÀ» °Ë»çÇÏ°Ô µÇ´Â µ¥ °¢ °Ë»çÄ¡¿¡´Â ¸ðµÎ Àǹ̰¡ ÀÖÀ¸¸ç, ÀÌ °Ë»ç Çϳª·Î °£±â´ÉÀÇ Àü¹ÝÀûÀÎ »óÅ¿¡ ´ëÇØ¼ ¾Ë¾Æº¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | pulmonary function tests | ÇÑ±Û | Æó±â´É °Ë»ç |
|---|---|---|---|
| ¼³¸í | ¿©·¯ °¡Áö ±â±¸¸¦ ÀÌ¿ëÇØ Æó¿ëÀû ¹× ÇãÆÄÀÇ È®»ê´ÉÀ» ¾Ë¾Æº¸´Â °Ë»ç·Î ¸» ±×´ë·Î ÇãÆÄÀÇ ±â´ÉÀ» ÃøÁ¤ÇÏ´Â °Ë»çÀÌ´Ù. |
||
| PULSES | physical condition, upper limb function, lower limb function, sensory component, excretory function,... |
|---|---|
| CSR | central supply room; chart-stimulated recall [test]; Cheyne-Stokes respiration; continued stay revie... |
| RFS | relapse-free survival; renal function study; rotating frame spectroscopy |
| PFT | 1) Platelet Function Test 2) Pulmonary Function Test |
| LFA | left femoral artery; left frontal craniotomy; left fronto-anterior [fetal position]; leukocyte funct... |
| CSS | Cause specific survival |
|---|---|
| S | D)--survival |
| DFS | Disease free survival |
| DSS | Disease specific survival |
| DDFS | Distant disease-free survival |
| median survival | <statistics> Median means the middle value. An equal number of people live longer as die earlier than the median. (16 Dec 1997) |
|---|---|
| cell survival | The span of viability of a cell characterised by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. (12 Dec 1998) |
| graft survival | <haematology> The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. (12 Dec 1998) |
| survival | 1. A living or continuing longer than, or beyond the existence of, another person, thing, or event; an outliving. 2. Any habit, usage, or belief, remaining from ancient times, the origin of which is often unknown, or imperfectly known. "The close bearing of the doctrine of survival on the study of manners and customs." (Tylor) Survival of the fittest. <biology> See Natural selection, under Natural. Origin: From Survive. Source: Websters Dictionary (01 Mar 1998) |
| survival analysis | A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. (12 Dec 1998) |
| survival rate | The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. (12 Dec 1998) |
| survival time | The period elapsing between the completion or institution of any procedure and death, the life-span of biologically or physically marked erythrocytes or other cells. (05 Mar 2000) |
| disease-free survival | Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. (12 Dec 1998) |
| tissue survival | The span of viability of a tissue or an organ. (12 Dec 1998) |
| five year survival rate | The proportion of patients still alive five years after a diagnosis or form of treatment is completed. Usually applied to statistics of survival of cancer patients, since after five years, recurrences are much less likely to occur. (05 Mar 2000) |
| 5-year relative survival rate | <statistics> The likelihood that a patient will not die from causes associated with his or her cancer for at least 5 years after diagnosis. This is the standard many professionals use when determining someone a survivor of cancer. (16 Dec 1997) |
| long-term survival | <oncology> Term used to describe the survival of leukaemia patients who have been disease free for prolonged periods of time, usually at least five years. The chance of disease returning (relapse) decreases with time. (13 Nov 1997) |
| acquired platelet function defect | <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines). Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation. (29 Dec 1997) |
| allomeric function | The combined function of the several segments of the spinal cord and medulla, communicating with each other by means of the white matter. (05 Mar 2000) |
| aperture function | <microscopy> In a diffraction-limited optical system, the function that determines the relationship between the image and each point in the object. Modifying the aperture function changes the image according to the modified Fourier-filtering (or optical filtration) property of the aperture. (05 Aug 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|